… In the context of the health emergency related to SARS CoV2 infection and COVID-19-related
interstitial lung disease, such knowledge holds decisive relevance in the conscious choice …

… COVID-19 pneumonia was ruled out with two negative PCR … Mesalazine-induced interstitial
pneumonitis is a reversible … drug (2,3) following a variable time period (few days-40 months). …

… [23], and its incidence appeared to have been reducing in the era of lung protective ventilation
[24]. A … Outcome of hospitalization for COVID-19 in patients with interstitial lung disease an …

… risk in the setting of COVID-19 interstitial pneumonia [2], [3]. … of COVID-19 interstitial
pneumonia. We retrospectively enrolled elderly patients affected by COVID-19 interstitial pneumonia …

… It has poor specificity due to overlap with other pulmonary diseases (ie, viral pneumonias,
pulmonary edema, interstitial lung disease), and therefore cannot be used as a confirmatory …

… over the telephone during this period of COVID-19. However, the … pulmonary consequences
of COVID-19 remain speculative … interstitial pneumonia/fibrotic ILD in survivors of COVID-19 …

… era of COVID-19 poses several challenges. Similar to patients who develop IR-pneumonitis,
those with COVID-19 … of interstitial pneumonias and related conditions including (1) acute …

… in 2020 compared to the same period in 2019. In 2020, … of interstitial lung disease (AE-ILD)
[2], COVID-19 may be … -idiopathic pulmonary fibrosis (IPF) associated with COVID-19, …

… Our findings offer insights into a distinct form of MDA5+ disease in the COVID-19 era that
we term MIP-C. A relationship between circulating SARS-CoV-2 viral waves, the potential risk …

… coronavirus 2 (SARS-CoV-2) interstitial pneumonia show overlapping clinical features. As
we are facing the COVID-19 … between COVID-19 and radiation therapy-related pneumonitis (…